ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Rise in diabetes in Asia fuels demand for tests

Greater need for diagnostics in India, Southeast Asia along with prosperity

CMIC technicians conduct urinalysis testing in Vietnam.

TOKYO -- Japanese manufacturers of diagnostic tests for diabetes and other illnesses are ramping up operations in the rest of Asia, as they hope to catch up with global players by tapping into emerging markets.

In Southeast Asia, CMIC Holdings is launching a diabetes diagnostics business geared toward the affluent. The company recently received regulatory approval for its diabetes tests in the Philippines and Vietnam. CMIC will offer a service that can predict kidney disease, based on artificial intelligence that analyzes data collected at hospitals using its tests.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more